Investors are always looking for stocks that are poised to beat at earnings season and Shockwave Medical, Inc. SWAV may be one such company. The firm has earnings coming up pretty soon, and events are ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. Mid-cap ...

Investors in ShockWave Medical Inc (Symbol: SWAV) saw new options begin trading today, for the December 2024 expiration. One of the key data points that goes into the price an option buyer is willing ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the ...

Shockwave Medical specializes in developing and commercializing medical devices using IVL technology for treating calcified plaque in vascular and heart valve diseases. The company has achieved ...

Shockwave Medical Inc. is a medical device developer focusing on calcified cardiovascular disease treatments, with a promising market opportunity. SWAV recently completed the acquisition of Neovasc ...

In a report released today, Cecilia Furlong from Morgan Stanley maintained a Hold rating on Shockwave Medical (SWAV – Research Report), with a price target of $291.00. The company’s shares closed ...